Psychology Today51%
The Science Behind Finding the Optimal ADHD Medication Dose 5%
By Rachel Diamond Ph.D.0%
7/15/2026, 6:19:24 PM
BS Summary: This article contains 5 faulty reasoning types, including Hasty Generalization, False Dilemma, and Optimism Bias, with Indoctrination as the most egregious example at 9.9% saturation with 65 hits. Analysis detected 188 faulty-reasoning hits from 656 analyzed words, generating a BS Score of 20.5% and a BS Rank of 5% (15,454 of 16,251 articles). This article is better (less manipulative) than 95.10% of the article peer group.
Starting ADHD medication is often just the beginning of treatment.
For many adults or parents of children with ADHD, it comes with many questions: "Is the dose too high or not enough?"
“How do I know when I've found the right dose?"
A new systematic review published in The Lancet Psychiatry can help shed light on this process.
Researchers analyzed data from 113 clinical trials that included over 25,000 youth (ages 5-18) and adult participants prescribed ADHD medications, including methylphenidate, amphetamines, atomoxetine, guanfacine, and viloxazine.
Their goal was to identify the dose at which ADHD medications provide the greatest symptom management with the lowest risk of side effects across the different age groups.
Finding this balance in dosage matters.
If a person is prescribed too low a dose, the medication isn't able to effectively manage symptoms.
This can be common, especially in children and adolescents, potentially leading to discontinuation of medication because of the perception that it isn't working.
On the other hand, prescribing too high a dose can cause unnecessary side effects to outweigh additional benefits, which can also commonly lead to medication discontinuation.
The goal is to find the “sweet spot,” the lowest therapeutic dose that provides meaningful symptom improvements with minimal side effects.
Findings
Across medications and age groups, researchers found that increasing the dose tended to improve symptom management, but only to a point.
Once an optimal dose range was reached, a general ceiling effect was observed for most medications.
In other words, additional increases past the optimal range provided limited (or even reduced) effectiveness while also increasing the likelihood of side effects.
For children and adolescents, the greatest average benefit was estimated at approximately 45 mg/day for methylphenidate, 25 mg/day for amphetamine-based medications, and 4 mg/day for guanfacine.
On average, increasing doses beyond these levels did not provide additional symptom improvement; instead, side effects became more common.
For adults, amphetamine-based medications reached an effectiveness plateau around 50 mg/day.
Methylphenidate continued to show increasing benefit across the doses studied, although improvements became progressively smaller while side effects increased at higher doses.
A few study limitations are important to note when interpreting these findings.
The findings of this study report group-level averages; as such, they cannot inform individual-level medication dosage decisions.
Furthermore, this study wasn't able to look for age-related differences within the under-18 population.
Rather than examining the dosage needs for children (aged ≥5 to <12 years) and adolescents (aged ≥12 to <18 years), relatively small sample sizes required researchers to combine all individuals under 18 into a single analysis.
This means the reported dose-response curves represent an average across all youth (ages 5-18).
Meaningful developmental differences may exist, but this study wasn't able to evaluate them.
Similarly, researchers could not determine dose-response patterns based on race and gender.
Medication response is impacted by many factors, such as body size, metabolism, and comorbidities (e.g., autism spectrum disorder, mood disorders, insomnia).
As such, it is important to work with a medical professional to receive a careful evaluation, ongoing monitoring, and an individualized treatment plan.
Takeaways
This research suggests that finding the right ADHD medication dose is about identifying the point where symptom improvement is greatest relative to side effects, not simply continuing to increase the dose.
For many medications, symptom improvement eventually levels off, while the likelihood of side effects continues to rise.
These findings reinforce why ADHD medications are typically started at a low dose and gradually increased over time, a process called titration.
While no study can determine the right dosage of medication for every person, this research provides exciting new evidence about optimal dosage ranges for many ADHD medications.
Ultimately, my hope in sharing this research is to support readers in having informed, collaborative conversations and to help guide readers in asking an important question of their healthcare provider: What medication dosage provides the greatest benefit with the fewest side effects?
Analysis
Hover over highlighted words in the article to view the associated bias or fallacy analysis.